-
公开(公告)号:US20240123061A1
公开(公告)日:2024-04-18
申请号:US18533676
申请日:2023-12-08
Applicant: University of Washington , ABACUS BIOSCIENCE, INC.
Inventor: Edward A. CLARK , Deborah L. FULLER , Che-Leung LAW , Amanda MAK
CPC classification number: A61K39/292 , A61K39/001129 , A61K39/39 , C07K16/2896 , C12N7/00 , C07K2317/524 , C07K2317/526 , C07K2317/56 , C07K2317/622 , C07K2319/00 , C12N2730/10134
Abstract: Provided herein are compositions of CD1280 binding proteins and a Hepatitis B virus core antigen (HBcAg) and/or a Hepatitis B virus E antigen (HBeAg), or antigenic fragments or mutants thereof, attached to the CD180 binding protein, and methods for using the compositions to treat or limit the development of hepatitis-B virus (HBV)-related disorders.
-
公开(公告)号:US20220241403A1
公开(公告)日:2022-08-04
申请号:US17721554
申请日:2022-04-15
Applicant: UNIVERSITY OF WASHINGTON , ABACUS BIOSCIENCE, INC.
Inventor: Edward A. CLARK , Deborah L. FULLER , Che-Leung LAW , Amanda MAK
Abstract: Provided herein are compositions of CD1280 binding proteins and a Hepatitis B virus core antigen (HBcAg) and/or a Hepatitis B virus E antigen (HBeAg), or antigenic fragments or mutants thereof, attached to the CD180 binding protein, and methods for using the compositions to treat or limit the development of hepatitis-B virus (HBV)-related disorders.
-
公开(公告)号:US20200306367A1
公开(公告)日:2020-10-01
申请号:US16088386
申请日:2016-11-22
Applicant: UNIVERSITY OF WASHINGTON
Inventor: Edward CLARK , Deborah L. FULLER , Che-Leung LAW , Amanda MAK
Abstract: Provided herein are compositions of CD1280 binding proteins and a Hepatitis B virus core antigen (HBcAg) and/or a Hepatitis B virus E antigen (HBeAg), or antigenic fragments or mutants thereof, attached to the CD180 binding protein, and methods for using the compositions to treat or limit the development of hepatitis-B virus (HBV)-related disorders.
-
-